Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00872339 · ClinicalTrials.gov registry record
Assessment of Pain in People With Thalassemia
A clinical trial, sponsored by Carelon Research.
- Completed
- Registry status
- 252
- Enrollment target
NCT00872339: Completed study, sponsored by Carelon Research.
NCT00872339 is a clinical trial that has completed, run by Carelon Research. The registered enrollment target is 252 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00872339 has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- 252 participants
- Enrollment target
Study Summary
Thalassemia is an inherited blood disorder that can result in mild to severe anemia. People with thalassemia often experience pain, but the exact sources and prevalence of pain remain unknown. This study will examine the prevalence and severity of pain in people with thalassemia who are treated with regular blood transfusions and people with thalassemia who are not treated with regular blood transfusions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-12 |
What the finished NCT00872339 record still lists
NCT00872339 is an observational study that tracks outcomes without assigning an intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00872339 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00872339 about?
NCT00872339 is a clinical study titled "Assessment of Pain in People With Thalassemia". Thalassemia is an inherited blood disorder that can result in mild to severe anemia. People with thalassemia often experience pain, but the exact sources and prevalence of pain remain unknown. This study will examine the prevalence and severity of pain in people with thalassemia who are treated with...
What is the current status of trial NCT00872339?
This trial is currently completed. The enrollment target is 252 participants. The study started on 2009-03. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT00872339?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia